{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:02:12Z","timestamp":1790996532314,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["01984"],"award-info":[{"award-number":["01984"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2018\\u201301984"],"award-info":[{"award-number":["2018\\u201301984"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["03254"],"award-info":[{"award-number":["03254"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["02979"],"award-info":[{"award-number":["02979"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018\\u201302979"],"award-info":[{"award-number":["2018\\u201302979"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2014\\u201303254"],"award-info":[{"award-number":["2014\\u201303254"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.neuropharm.2020.108136","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T04:09:03Z","timestamp":1590725343000},"page":"108136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism"],"prefix":"10.1016","volume":"174","author":[{"given":"Giacomo","family":"Sitzia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Mantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Chergui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108136_bib1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1124\/mol.62.5.1119","article-title":"Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits","volume":"62","author":"Al-Hallaq","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108136_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/mds.27554","article-title":"A chemogenetic approach for treating experimental Parkinson's disease","volume":"34","author":"Assaf","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2020.108136_bib4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2402638","article-title":"Reversal of experimental parkinsonism by lesions of the subthalamic nucleus","volume":"249","author":"Bergman","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108136_bib5","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jnr.24230","article-title":"NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate","volume":"96","author":"Bhattacharya","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2020.108136_bib6","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1523\/JNEUROSCI.3065-06.2006","article-title":"Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata","volume":"26","author":"Boulet","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(00)00432-2","article-title":"Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra","volume":"101","author":"Chatha","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108136_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0079-6123(06)60009-5","article-title":"The pars reticulata of the substantia nigra: a window to basal ganglia output","volume":"160","author":"Deniau","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108136_bib10","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jnr.24574","article-title":"Roles of GluN2C in cerebral ischemia: GluN2C expressed in different cell types plays different role in ischemic damage","volume":"98","author":"Ding","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2020.108136_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","article-title":"Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease","volume":"57","author":"Dunah","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108136_bib49","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0022-3565(24)37138-1","article-title":"Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro","volume":"283","author":"Fischer","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2020.108136_bib50","doi-asserted-by":"crossref","first-page":"18531","DOI":"10.1523\/JNEUROSCI.1278-13.2013","article-title":"Control of basal ganglia output by direct and indirect pathway projection neurons","volume":"33","author":"Freeze","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0079-6123(10)83009-2","article-title":"Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease","volume":"183","author":"Gardoni","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108136_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.neuron.2014.01.035","article-title":"Distinct functional and pharmacological properties of Triheteromeric GluN1\/GluN2A\/GluN2B NMDA receptors","volume":"81","author":"Hansen","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108136_bib15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108136_bib51","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1152\/jn.00620.2007","article-title":"Bursting in substantia nigra pars reticulata neurons in vitro: possible relevance for Parkinson disease","volume":"98","author":"Ibanez-Sandoval","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108136_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mds.25273","article-title":"Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials","volume":"28","author":"Kalia","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2020.108136_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.mcn.2006.12.001","article-title":"Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta-galactosidase knock-in mice","volume":"34","author":"Karavanova","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib18","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/brain\/124.10.2105","article-title":"Lidocaine and muscimol microinjections in subthalamic nucleus reverse Parkinsonian symptoms","volume":"124","author":"Levy","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2020.108136_bib19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1126\/science.aaz0956","article-title":"A common hub for sleep and motor control in the substantia nigra","volume":"367","author":"Liu","year":"2020","journal-title":"Science"},{"issue":"1005","key":"10.1016\/j.neuropharm.2020.108136_bib20","first-page":"1","article-title":"Cellular and synaptic dysfunctions in Parkinson\u2019s disease: stepping out of the striatum","volume":"8","author":"Mallet","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2020.108136_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nn.4559","article-title":"Cell-specific pallidal intervention induces long-lasting motor recovery in dopamine-depleted mice","volume":"20","author":"Mastro","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fncel.2015.00245","article-title":"NMDA receptor GluN2A\/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients","volume":"9","author":"Mellone","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib52","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108136_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mds.10107","article-title":"Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat","volume":"17","author":"Nash","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2020.108136_bib25","doi-asserted-by":"crossref","first-page":"RC185","DOI":"10.1523\/JNEUROSCI.21-23-j0003.2001","article-title":"Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner","volume":"21","author":"Nishi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1126\/science.aax1522","article-title":"Control of aversion by glycine-gated GluN1\/GluN3A NMDA receptors in the adult medial habenula","volume":"366","author":"Otsu","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108136_bib27","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1523\/JNEUROSCI.2149-10.2010","article-title":"Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition","volume":"30","author":"Paill\u00e9","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib28","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1172\/JCI75587","article-title":"Deranged NMDAergic cortico-subthalamic transmission underlies parkinsonian motor deficits","volume":"124","author":"Pan","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2020.108136_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2018.03.011","article-title":"Region-specific expression of NMDA receptor GluN2C subunit in parvalbumin-positive neurons and astrocytes: analysis of GluN2C expression using a novel reporter model","volume":"380","author":"Ravikrishnan","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108136_bib31","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.celrep.2019.04.068","article-title":"Synergistic nigral output pathways shape movement","volume":"27","author":"Rizzi","year":"2019","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108136_bib32","doi-asserted-by":"crossref","first-page":"S534","DOI":"10.1002\/mds.22027","article-title":"Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains","volume":"23","author":"Smith","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2020.108136_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.903430102","article-title":"Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat","volume":"343","author":"Standaert","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108136_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cophys.2017.12.004","article-title":"Triheteromeric NMDA receptors: from structure to synaptic physiology","volume":"2","author":"Stroebel","year":"2018","journal-title":"Current opin. physiol."},{"key":"10.1016\/j.neuropharm.2020.108136_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1460-9568.2010.07298.x","article-title":"Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones","volume":"32","author":"Su\u00e1rez","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib35","doi-asserted-by":"crossref","first-page":"15971","DOI":"10.1523\/JNEUROSCI.1702-15.2015","article-title":"NMDA receptors containing the GluN2D subunit control neuronal function in the subthalamic nucleus","volume":"35","author":"Swanger","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopsych.2015.08.013","article-title":"Alpha-synuclein produces early behavioral alterations via striatal cholinergic synaptic dysfunction by interacting with GluN2D N-Methyl-D-Aspartate receptor subunit","volume":"79","author":"Tozzi","year":"2016","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108136_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0006-8993(99)02292-1","article-title":"Cellular expression of ionotropic glutamate receptor subunits in subpopulations of neurons in the rat substantia nigra pars reticulata","volume":"854","author":"Tse","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108136_bib38","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1152\/jn.1998.79.2.555","article-title":"Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors","volume":"79","author":"Vicini","year":"1998","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108136_bib39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11064-015-1794-8","article-title":"Ontogenic profile and synaptic distribution of GluN3 proteins in the rat brain and hippocampal neurons","volume":"41","author":"Wee","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2020.108136_bib40","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/mds.27741","article-title":"Changing views of the pathophysiology of Parkinsonism","volume":"34","author":"Wichmann","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2020.108136_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42746","article-title":"State transitions in the substantia nigra reticulata predict the onset of motor deficits in models of progressive dopamine depletion in mice","volume":"8","author":"Willard","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2020.108136_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2013.01.016","article-title":"Influence of GluN2 subunit identity on NMDA receptor function","volume":"74","author":"Wyllie","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108136_bib43","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1113\/JP278168","article-title":"Functional and pharmacological properties of triheteromeric GluN1\/2B\/2D NMDA receptors","volume":"597","author":"Yi","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108136_bib44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1227\/NEU.0000000000000297","article-title":"Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of Parkinson disease","volume":"74","author":"Yoon","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuropharm.2020.108136_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2015.01.007","article-title":"Dopamine depletion of the striatum causes a cell-type specific reorganization of GluN2B- and GluN2D-containing NMDA receptors","volume":"92","author":"Zhang","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108136_bib46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jnc.12658","article-title":"GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease","volume":"129","author":"Zhang","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108136_bib47","article-title":"Roles of glutamate receptors in Parkinson's disease","volume":"20","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108136_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuroscience.2011.07.061","article-title":"Intrinsic and integrative properties of substantia nigra pars reticulata neurons","volume":"198","author":"Zhou","year":"2011","journal-title":"Neuroscience"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820302045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820302045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:36:34Z","timestamp":1777426594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820302045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":52,"alternative-id":["S0028390820302045"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108136","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108136"}}